Marapharm Ventures Announces Private Placement Offering

Published: May 17, 2018

Marapharm Ventures Announces Private Placement Offering

Marapharm Ventures Inc. intends to proceed with a non-brokered private placement of up to 6,666,667 Units at $0.60 per Unit to raise gross proceeds of up to $4,000,000. The Unit will consist of one common share of the Company and one-half of one common share purchase warrant of the Company. Each warrant entitles the holder thereof to purchase one Common Share of the Company at an exercise price of $0.70 for a period of 12 months from the date of issuance of the warrant.

 

Pursuant to the terms of the warrants, the expiry date of the warrants may be accelerated should the closing price at which the common shares trade exceeds $0.85 for five consecutive trading days. Any warrants which remain unexercised after the accelerated expiry date will be cancelled.

 

The net proceeds raised from the Unit Offering are intended to be used for (i) further development of the Company’s Las Vegas project (ii) further development of the Company’s project in Washington State (iii) further development of the Company’s projects in California and general corporate purposes.